diabetic%20ketoacidosis%20-and-%20hyperosmolar%20hyperglycemic%20state
DIABETIC KETOACIDOSIS & HYPEROSMOLAR HYPERGLYCEMIC STATE
Diabetic ketoacidosis is characterized by having blood glucose >13.9 mmol/L, arterial pH <7.3 in adults or venous pH <7.3 in pediatrics, bicarbonate <15 mEg/L, moderate ketonuria or ketonemia and anion gap >14.
Hyperosmolar Hyperglycemic state in adults is described as having blood glucose >33.3 mmol/L, arterial pH >7.3, bicarbonate >15 mEq/L, mild ketonuria or ketonemia, effective serum osmolality >320 mOsm/kg and variable anion gap.
While hyperosmolar Hyperglycemic state in pediatric patients have blood glucose >33.3 mmol/L, venous pH >7.3, bicarbonate >15 mEq/L and altered mental status or severe dehydration.

Monitoring

Adult diabetic ketoacidosis (DKA)

  • Check glucose, blood urea nitrogen (BUN), creatinine, & electrolytes every 2-4 hours until stable
  • Continue to investigate precipitating causes & treat appropriately

Criteria for Resolution of DKA:

  • Blood glucose <200 mg/dL
  • Venous pH >7.3
  • Bicarbonate ≥15 mEq/L

After Resolution of DKA:

  • If patient is nothing by mouth/non per os (NPO), continue intravenous (IV) insulin & supplement w/ Regular insulin subcutaneous (SC) as required every 4 hours

Once patient is able to eat:

  • Start multidose insulin regimen & adjust as required
  • IV insulin should be continued for 1-2 hours after SC insulin is started

Adult hyperosmolar hyperglycemic state (HHS)

  • Check BUN, creatinine, electrolytes, & glucose every 2-4 hours until stable
  • Continue to investigate precipitating causes & treat appropriately

After Resolution of HHS:

  • If patient is NPO continue IV insulin & supplement w/ SC insulin as required

Once patient is able to eat:

  • Start multidose insulin regimen (such as SC), or give as previous treatment & check metabolic control

Pediatric DKA & HHS

  • Check glucose & electrolytes every 2-4 hours until stable
  • Continue to investigate precipitating causes & treat appropriately

After Resolution of DKA:

  • Start SC insulin (0.5-1 U/kg/day)
    • Give 2/3 of the total daily dose in the AM (1/3 short-acting & 2/3 of dose intermediate-acting insulin)
    • Give 1/3 of total daily dose in the PM (1/2 short-acting & 1/2 of dose intermediate-acting insulin)
  • Or give 0.1-0.25 U/kg SC of Regular insulin every 6-8 hours for the first 24 hours to determine insulin requirements
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Jan 2016
The thyroid gland was hypovascular, coarse,  hyperechoic, and had substantially decreased in mean total volume among Graves' hyperthyroidism patients following radioiodine therapy, based on a study
02 Jun 2017

Abnormal lung function and histological features have been found in diabetics, and there is enough evidence showing that the lungs are another target organ of diabetes, says a specialist at the 9th Diabetes Complications Conference and Grand Rounds organized by the National Diabetes Institute (NADI).

6 days ago
Global hypomethylation of Alu appears to increasingly influence distant metastatic differentiated thyroid cancer (DTC), poorly (P)DTC and anaplastic (A)TC, according to a recent study. This suggests that the epigenetic entity may be involved in thyroid cancer progression and dedifferentiation.
01 Nov 2015
Increased serum prolidase levels in Grave's disease patients without ophthalmopathy signs are positively associated with oxidative stress parameters as shown in a study.